We have located links that may give you full text access.
Treatment Response Evaluation using Yttrium-90 in Patients with Rheumatoid Arthritis of Knee Joint.
World Journal of Nuclear Medicine 2018 January
For radiosynovectomy, we have measured the retention time of yttrium-90 (90 Y) hydroxyapatite (particle size 1-10 μm) within the knee joint space and evaluated the treatment responses in knees with rheumatoid arthritis. Radioactive measurements in the region of knee after injection of 90 Y hydroxyapatite into the joint space were made with a single prove system designed to monitor radioactivity and showed retention of 90 Y in the knee ranged 76.6% ±5.4% after 4 days of injection. The clinical improvements in rheumatoid arthritis of knee joint with steinbroker Stages I and II were increased as time goes by, the improvement ratio is in 72% at 6th months and 76% at 12th months after injection of 90 Y 185 MBq (5 mCi) per joint.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app